Xenetic Biosciences, Inc. current report, 08 October 2013

Business Context and Reporting Period

This Form 8-K was filed by General Sales and Leasing, Inc. (not Xenetic Biosciences, Inc.) on October 8, 2013. The report details a corporate restructuring involving the transfer of assets to a subsidiary and a significant change in company control.

Key Financial Metrics

The filing does not provide standard financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The only financial figure disclosed is the transaction price for a stock transfer: $500 for 100,000,000 shares.

Material Changes

  • Asset Transfer: On October 8, 2013, the company entered into a Contribution Agreement transferring all assets and liabilities related to its aircraft ownership and rental business to its wholly-owned subsidiary, General Aircraft, Inc.
  • Change of Control: Ian Johnson transferred 100,000,000 shares of common stock to Oxbridge Technology Partners for $500. Consequently, Oxbridge Technology Partners now owns 74% of the issued and outstanding common stock, resulting in a change of control.

Outlook, Risks, and Management Commentary

Management confirmed there were no arrangements regarding the election of directors or other matters between the parties involved in the stock transfer. The filing states there are no known arrangements that may result in a subsequent change of control. No specific guidance, risks, or contingencies regarding future operations were detailed in this report.

Investor Verification Checklist

  • Verify the exact nature of the assets and liabilities transferred to General Aircraft, Inc.
  • Confirm the total number of outstanding shares to validate the 74% ownership stake held by Oxbridge Technology Partners.
  • Review the full text of the Contribution Agreement (Exhibit 10.1) for any hidden obligations or conditions.
  • Investigate the background and financial standing of Oxbridge Technology Partners as the new controlling shareholder.